In addition, GRP78 level on the surface of cancer cells has been found in prostate cancer studies to be related to tumor stage, and the level of anti-GRP78 antibody is parallel to the concentration of tumor-specific antigen in serum (27, 37, 38), which further suggests the effect of GRP78 on driving tumor progression. The gene discussed is HSPA5; the disease is prostate cancer.